ClinicalTrials.gg
Drug

Olmesartan clinical trials

Includes 46 studies of Olmesartan Medoxomil.

studies test it
64
open now
2
in phase 3
25
first study started
2000

How each study uses olmesartan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the olmesartan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 Apr 2002 · BENICAR · NDA 021286 (FDA, Drugs@FDA; as Olmesartan Medoxomil)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Olmesartan
12
Benicar HCT®
2

In one entry with another drug

Given together, or one or the other

Olmesartan/amlodipine
2

Studies by the year they started

61 studies that test it; most in 2005 (14)

Studies that test olmesartan, by start year
YearStudies
20001
20011
20022
20033
20044
200514
20065
20072
20085
20095
20103
20112
20121
20142
20154
20181
20191
20212
20221
20241
20261

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
4
Phase 3
25
Phase 4
25
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 40 · Other 24

Daiichi Sankyo (20) · Sankyo Pharma Gmbh (7) · Mylan Pharmaceuticals Inc (2) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (2) · Daiichi Sankyo Co., Ltd. (2) · EMS (2) · Tri-Service General Hospital (TSGH) (1) · Seoul National University Bundang Hospital (1)

Often tested with

Tested in the same studies.

Amlodipine (16) · Hydrochlorothiazide (13) · Losartan (5) · Dapagliflozin (2) · Rosuvastatin (2) · Irbesartan (2) · Valsartan (2) · Telmisartan (2)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses olmesartan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 64

See all 64 studies that test olmesartan →

Given beside what is tested · 6 — olmesartan is usual care or a partner of the new treatment
As the comparator · 20 — what is tested is compared with olmesartan

Codes

What other systems call olmesartan · ClinicalTrials.gg INT004387

  • MeSH (NLM) C437965olmesartanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 8W1IQP3U10OLMESARTANConfirmed FDA, NLM, Wikidata
  • RxNorm 321064Confirmed FDA, Wikidata
  • Wikidata Q421156olmesartanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66253OlmesartanOne source FDA
  • DrugBank DB00275One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.